Showing results (201-210 of 598) with videos related to
Sort By:
Pageof 60
Oncotarget|May 1, 2018
BNIP3 modulates the interface between B16-F10 melanoma cells and immune cellsErminia Romano, Nicole Rufo, Hannelie Korf, et al.Journal of Cellular Biochemistry|January 10, 2003
Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulatorsEvelyne Van Etten, Brigitte Decallonne, Lieve Verlinden, et al.The Lancet. Diabetes & Endocrinology|November 18, 2021
Glycaemic management in diabetes: old and new approachesAntonio Ceriello, Francesco Prattichizzo, Moshe Phillip, et al.Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2024
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative reviewDavid Russell-Jones, Timothy S Bailey, Wendy Lane, et al.Diabetes|October 24, 2018
Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 DiabetesMijke Buitinga, Aïsha Callebaut, Fernanda Marques Câmara Sodré, et al.The Journal of Clinical Endocrinology and Metabolism|April 27, 2012
Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery diseaseMaarten Hulsmans, Peter Sinnaeve, Bart Van der Schueren, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusionHiroaki Kitade, Masaru Kawai, Omer Rutgeerts, et al.Diabetes Care|March 29, 2002
Sexual dysfunction in women with type 1 diabetes: a controlled studyPaul Enzlin, Chantal Mathieu, Annick Van den Bruel, et al.Diabetes/Metabolism Research and Reviews|October 7, 2006
Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patientsVolkert A L Huurman, Katelijn Decochez, Chantal Mathieu, et al.The Journal of Clinical Endocrinology and Metabolism|December 19, 2015
Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort StudyMarc Claesen, Pieter Gillard, Frank De Smet, et al.Pageof 60